1. Home
  2. PRTH vs BIOA Comparison

PRTH vs BIOA Comparison

Compare PRTH & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Priority Technology Holdings Inc.

PRTH

Priority Technology Holdings Inc.

HOLD

Current Price

$5.86

Market Cap

545.8M

Sector

Technology

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$19.70

Market Cap

443.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTH
BIOA
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
545.8M
443.9M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
PRTH
BIOA
Price
$5.86
$19.70
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$8.00
$33.33
AVG Volume (30 Days)
352.7K
1.0M
Earning Date
03-05-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.54
N/A
Revenue
$932,948,000.00
$5,917,000.00
Revenue This Year
$10.60
N/A
Revenue Next Year
$7.92
N/A
P/E Ratio
$11.10
N/A
Revenue Growth
9.51
N/A
52 Week Low
$4.44
$2.88
52 Week High
$12.47
$24.00

Technical Indicators

Market Signals
Indicator
PRTH
BIOA
Relative Strength Index (RSI) 51.79 61.35
Support Level $5.87 $18.20
Resistance Level $6.09 $21.53
Average True Range (ATR) 0.19 1.90
MACD 0.02 -0.17
Stochastic Oscillator 56.64 57.54

Price Performance

Historical Comparison
PRTH
BIOA

About PRTH Priority Technology Holdings Inc.

Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium business enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments, and Enterprise Payments. SMB Payments segment which generates the majority of revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging Priority's proprietary software platform, distributed through ISO; the B2B Payments segment provides AP automation solutions to corporations, software partners, & industry FIs: and Enterprise Payments segment provides embedded payment & treasury solutions to enterprise customers to modernize legacy platforms & accelerate software partners' strategies to monetize payments.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Share on Social Networks: